Kathrine E. Attfield

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

Adam Gregory, Calliope A. Dendrou, Kathrine E. Attfield et al. · Nature · 2012 · 376 citations · Full text

Disease Susceptibility, Tnf Receptor 1, Anti-tnf Therapy +12

The immunology of multiple sclerosis

Kathrine E. Attfield, Lise Torp Jensen, Max Kaufmann et al. · Nature reviews. Immunology · 2022 · 313 citations

Clinical Immunology, Autoimmune Disease, Medicine +6

Resolving <i>TYK2</i> locus genotype-to-phenotype differences in autoimmunity

Calliope A. Dendrou, Adrián Cortés, Lydia Shipman et al. · Science Translational Medicine · 2016 · 241 citations · Full text

Immunology, Genetic Epidemiology, Immunotherapy +17

Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activation

Stephen A. Beers, H.T. Claude Chan, Sonya James et al. · Blood · 2008 · 178 citations · Full text

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

Sandra Vergo, Matthew Craner, Ruth Etzensperger et al. · Brain · 2011 · 164 citations

Immunology, Neurological Progress, Cellular Physiology +21